Biopharma Culture

Pic:getty/uschools

DIA gears up for Global Annual Meeting

By Rachel Arthur

DIA, the professional global community for healthcare product development, will host its in-person Global Annual Meeting in Chicago on June 19-23.

Pic:getty/marianvejcik

CPHI NORTH AMERICA 2022

US pharma hubs: The rising stars to watch

By Rachel Arthur

CPhI North America 2022 host city Philadelphia is set to become one of the world’s biggest cell and gene therapy manufacturing hubs. But it’s just one of many centers of innovation that are helping drive the US pharma and biopharma industry.

Pic:getty/moyostudio

Syner-G Biopharma Group acquires Impact

By Rachel Arthur

Syner-G BioPharma Group, a provider of Chemistry, Manufacturing, and Controls (CMC) technical, regulatory, and compliance consulting services to the pharmaceutical and biotechnology industry, has acquired Impact Pharmaceutical Services.

Pic:getty/aelitta

DIA 2021 Annual Meeting

Skills of the future – and the future of work

By Rachel Arthur

Whether working in the pharmaceutical industry or in academia or government, the skills required to achieve, maintain and grow a career are vastly different today than they were 30 years ago. A session at DIA 2021 will put the spotlight on the skills...

Pic:getty/ipopba

Widening access to COVID-19 data

By Rachel Arthur

California information technology and services company Syntegra and the National Institutes of Health (NIH) have signed a partnership to 'democratize access to the largest set of COVID-19 patient records': with the use of Syntegra's synthetic...

GettyImages/19695866

Fire ant venom to combat thick skin

By Flora Southey

Researchers say compounds from fire ant venom could be used to develop psoriasis treatments which limit skin-thickening side effects.

Only female mosquitoes spread malaria

CRISPR editing gives mosquitoes malaria-resistant DNA

By Fiona BARRY

Scientists trying to curb malaria deaths usually concentrate on preventing mosquito bites or developing human vaccines and therapies, but novel gene-editing tool CRISPR is opening up another path.